139 related articles for article (PubMed ID: 6179595)
1. Bleomycin hydrolase activity and cytotoxicity in human tumors.
Lazo JS; Boland CJ; Schwartz PE
Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin hydrolase activity in pulmonary cells.
Lazo JS; Merrill WW; Pham ET; Lynch TJ; McCallister JD; Ingbar DH
J Pharmacol Exp Ther; 1984 Dec; 231(3):583-8. PubMed ID: 6209387
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity of bleomycin hydrolase.
Sebti SM; DeLeon JC; Ma LT; Hecht SM; Lazo JS
Biochem Pharmacol; 1989 Jan; 38(1):141-7. PubMed ID: 2462878
[TBL] [Abstract][Full Text] [Related]
5. Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.
Pei Z; Calmels TP; Creutz CE; Sebti SM
Mol Pharmacol; 1995 Oct; 48(4):676-81. PubMed ID: 7476893
[TBL] [Abstract][Full Text] [Related]
6. In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
Zuckerman JE; Raffin TA; Brown JM; Newman RA; Etiz BB; Sikic BI
Cancer Res; 1986 Apr; 46(4 Pt 1):1748-53. PubMed ID: 2418953
[TBL] [Abstract][Full Text] [Related]
7. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
[TBL] [Abstract][Full Text] [Related]
8. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
[TBL] [Abstract][Full Text] [Related]
9. Neutralization of bleomycin hydrolase by an epitope-specific antibody.
Morris G; Mistry JS; Jani JP; Mignano JE; Sebti SM; Lazo JS
Mol Pharmacol; 1992 Jul; 42(1):57-62. PubMed ID: 1378925
[TBL] [Abstract][Full Text] [Related]
10. [Chemosensitivity of adriamycin, mitomycin C, and bleomycin with in vitro colony assay].
Miyamoto H; Inoue K; Arakawa M; Ogawa M
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1921-7. PubMed ID: 6191690
[TBL] [Abstract][Full Text] [Related]
11. Increased glutathione level is not involved in enhanced bleomycin sensitivity in cisplatin-resistant 2780CP cells.
Tanaka T; Kurokawa H; Matsuno K; Matsumoto S; Hayashida Y
Anticancer Res; 2008; 28(5A):2663-8. PubMed ID: 19035292
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of fluoromycin: a novel fluorescence-labeled derivative of talisomycin S10b.
Mistry JS; Jani JP; Morris G; Mujumdar RB; Reynolds IJ; Sebti SM; Lazo JS
Cancer Res; 1992 Feb; 52(3):709-18. PubMed ID: 1370650
[TBL] [Abstract][Full Text] [Related]
13. [Sensitivity to bleomycin of human cultured tumor cells and analysis of related factors].
Urade M; Sugi M; Shirasuna K; Sugiyama M; Miyazaki T
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2382-8. PubMed ID: 6195972
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of antioxidant enzymes and coenzyme Q(10) in a human oral cancer cell line with acquired bleomycin resistance.
Yen HC; Li SH; Majima HJ; Huang YH; Chen CP; Liu CC; Tu YC; Chen CW
Free Radic Res; 2011 Jun; 45(6):707-16. PubMed ID: 21486114
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of bleomycin-resistant HeLa cells and analysis of resistance mechanism.
Urade M; Sugi M; Matsuya T
Jpn J Cancer Res; 1988 Apr; 79(4):491-500. PubMed ID: 2454906
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary fate of [3H]bleomycin A2 in mice.
Lazo JS; Pham ET
J Pharmacol Exp Ther; 1984 Jan; 228(1):13-8. PubMed ID: 6198509
[TBL] [Abstract][Full Text] [Related]
17. Separation of the protective enzyme bleomycin hydrolase from rabbit pulmonary aminopeptidases.
Sebti SM; Lazo JS
Biochemistry; 1987 Jan; 26(2):432-7. PubMed ID: 3103681
[TBL] [Abstract][Full Text] [Related]
18. [The mode of action of bleomycin-cell kinetic investigations (author's transl)].
Ganzer U
Laryngol Rhinol Otol (Stuttg); 1978 Mar; 57(3):177-86. PubMed ID: 77461
[TBL] [Abstract][Full Text] [Related]
19. Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase.
Montoya SE; Ferrell RE; Lazo JS
Cancer Res; 1997 Oct; 57(19):4191-5. PubMed ID: 9331073
[TBL] [Abstract][Full Text] [Related]
20. [Combined effect of bleomycin and SDB-ethylenediamine, a synthetic isoprenoid, on oral squamous carcinoma cell lines and transplantable nude mouse tumors].
Takahashi Y; Urade M; Kishimoto H; Arimoto T; Yanagisawa T; Yoshioka W
Gan To Kagaku Ryoho; 1995 Jun; 22(7):883-7. PubMed ID: 7540824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
